Comparison of Transforming Powder Dressing to NPIAP Recommended Standard of Care Therapies in Stage 2, 3 and 4 Pressure Injuries
Eligible age
18–85 yrs
Accepts
All genders
Locations
8 states
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Pressure injuries, commonly known as pressure ulcers, affect over 2.5 million people in the United States. Pressure injuries are classified into four escalating stages, from intact skin to full thickness wounds with deep tissue loss and exposed bone. This study will compare current standard of care treatment (as recommended by the National Pressure Injury Advisory Panel) to treatment with Altrazeal® in patients with stage 2, stage 3 and stage 4 pressure injury wounds. Altrazeal® is a Class 1, 501(k) exempt medical device listed with the FDA as a "dressing, wound, hydrogel" and has an extended wear time of up to 30 days. Subjects can be enrolled in the study either as an outpatient, or while hospitalized. Half of the subjects will be randomized to standard of care treatment, and the other half will be randomized to Altrazeal®. There are a total of up to 12 study visits taking place over 12 weeks.
Sponsor: ULURU Inc.
You may qualify if…
- ✓ 1. 18 to 85 years of age;
- ✓ 2. Stage 2, 3, or 4 Pressure Injuries;
- ✓ 3. Wound exudate is mild to moderate;
- ✓ 4. No clinically active wound infection (clinical diagnosis);
- ✓ 5. Able and willing to provide written (not proxy) informed consent;
- ✓ 6. Clinically stable, as determined by assessment of medical history, vital signs, physical examination, and laboratory testing prior to enrollment.
You may not qualify if…
- ✕ 1. Known allergy or hypersensitivity to TPD or its components;
- ✕ 2. Pressure injuries classified as unstageable, deep tissue pressure injury, or Stage 1;
- ✕ 3. Heavily exudative wounds;
- ✕ 4. Wound infection as defined as the presence of a least two of the following: local swelling or in duration, erythema \>0.5cm around the ulcer in any direction, local tenderness or pain local warmth and purulent discharge;
- ✕ 5. Poorly controlled diabetes with HgbA1C \>12 (as documented in the last 3 months);
- ✕ 6. Body Mass Index (BMI) \>45 kg/m2;
- ✕ 7. Venous stasis disease or lymphedema in the affected limb (if wound is located on the limb);
- ✕ 8. Moderate to severe chronic limb ischemia Ankle Brachial Index (ABI) \<0.7 on the affected limb, if wound is located on the limb);
Where it's recruiting
San Diego
Washington D.C.
Chicago
Baltimore
Newark
Lake Success · Mineola · The Bronx · Valhalla
Pittsburgh
Dallas · Houston
Source: ClinicalTrials.gov · NCT05496296 · last updated 2025-11-20